Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Untangling the ErbB signalling network
2001 Standout
EGFR and cancer prognosis
2001 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Cancer to bone: a fatal attraction
2011 Standout
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Androgen receptors in endocrine‐therapy‐resistant human prostate cancer
1991
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Growth factor-receptor pathway interfering treatment by somatostatin analogs and suramin: Preclinical and clinical studies
1990
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part I. Cell markers and immortalized nontumorigenic cell lines
1996
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Characterization of a 60-kDa cell surface-associated transforming growth factor-β binding protein that can interfere with transforming growth factor-β receptor binding
1997
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1996 Standout
Suramin-Induced Decrease in Prostate-Specific Antigen Expression With No Effect on Tumor Growth in the LNCaP Model of Human Prostate Cancer
1996
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation
1992
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
Legumes and soybeans: overview of their nutritional profiles and health effects
1999 Standout
Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
1993
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Chromosomal Localization, Structure, and Regulation of the UGT2B17 Gene, Encoding a C19 Steroid Metabolizing Enzyme
1997
Medicinal mushroom modulators of molecular targets as cancer therapeutics
2005 Standout
The Proteasome Is Involved in Angiogenesis
1998 StandoutNobel
The development of androgen-independent prostate cancer
2001 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Characterization of UDP-glucuronosyltransferases active on steroid hormones
1999
Insulin‐like growth factor I: Action and receptor characterization in human prostate cancer cell lines
1993
Defining Postpartum Uterine Disease and the Mechanisms of Infection and Immunity in the Female Reproductive Tract in Cattle1
2009 Standout
The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens
1992
Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation
2000
Androgen receptor gene mutations in human prostate cancer
1993
Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis
1994
Regulation of prostatic growth and function by peptide growth factors
1996
A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgens
1990
Hormone receptors in malignancy
1992
Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway
2000
Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation
1993
Anti‐proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down‐regulation and ceramide production
2003
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer
1996
Amino acids and immune function
2007 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Structure−Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)
2010
Stress-induced immune dysfunction: implications for health
2005 Standout
Bcl-xL Blocks Transforming Growth Factor-β1-induced Apoptosis by Inhibiting Cytochrome c Release and Not by Directly Antagonizing Apaf-1-dependent Caspase Activation in Prostate Epithelial Cells
2001
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
1999
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
2008 Standout
Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines
1999 Standout
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts.
1991
Growth factor involvement in progression of prostate cancer
1998
Response to Flutamide Withdrawal in Advanced Prostate Cancer in Progression Under Combination Therapy
1993
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
1997 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function
1997
The role of growth hormone in T-cell development and reconstitution
2002
The lipocalin protein family: structure and function
1996 Standout
Prostate cancer schemes for androgen escape
2000
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
1997 Standout
Testosterone up-regulates androgen receptors and decreases differentiation of porcine myogenic satellite cells in vitro.
1996
The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency*
2000
Suramin: a novel antineoplastic agent with multiple potential mechanisms of action.
1993
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Growth factor involvement in progression of prostate cancer.
1998
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Phytoestrogens: epidemiology and a possible role in cancer protection.
1995 Standout
Review of Peptide Growth Factors in Benign Prostatic Hyperplasia and Urological Malignancy
1995
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
2000 Standout
Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation12
2003
Stimulation of apolipoprotein D secretion by steroids coincides with inhibition of cell proliferation in human LNCaP prostate cancer cells.
1991
Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review
2007 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Overcoming Persistent Dependency on Androgen Signaling after Progression to Castration-Resistant Prostate Cancer
2010
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells
1999 StandoutNobel
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Androgen receptor gene mutations in human prostate cancer.
1992
Insulin Resistance and Atherosclerosis
2006
Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms.
1995
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
GROWTH FACTORS: ROLES IN ANDROLOGY
2001
Transforming growth factor β and cancer
1995
Works of A.L.G. Schuurmans being referenced
Antiproliferative effects of suramin on androgen responsive tumour cells
1990
Mechanism of androgen action: Recent observations on the domain structure of androgen receptors and the induction of EGF-receptors by androgens in prostate tumor cells
1989
Androgen Receptor-Mediated Growth and Epidermal Growth Factor Receptor Induction in the Human Prostate Cell Line LNCaP
1989
Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion
1990
Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP
1988
Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones
1991
Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids
1988
Androgens and transforming growth factor β modulate the growth response to epidermal growth factor in human prostatic tumor cells (LNCaP)
1988
Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells.
1992